Core Viewpoint - The Sichuan Provincial Drug Administration is actively enhancing drug regulation and quality control through a multi-faceted approach, focusing on safety, efficiency, and public welfare during the "14th Five-Year Plan" period [3][4][9]. Group 1: Regulatory Framework - The Sichuan Provincial Drug Administration is building a scientific and efficient drug regulatory system, emphasizing government leadership, departmental collaboration, and social governance [4]. - A clear responsibility system has been established to enhance regulatory effectiveness, with a three-tier and five-region regulatory framework [4]. - The administration has strengthened coordination with 26 departments to advance drug safety collectively [4]. Group 2: Digital Transformation - Digital transformation initiatives have made drug regulation smarter, with online processing for all regulatory procedures and an electronic traceability system for drugs [5]. - The implementation of a unique identification system for medical devices has resulted in over 22,600 data uploads, ranking eighth nationally [5]. - The establishment of seven key laboratories has positioned Sichuan as a leader in the western region for drug monitoring and safety [5]. Group 3: Talent Development - The administration has developed a professional title evaluation system for pharmaceutical engineering and non-clinical pharmacy, assessing 199 individuals to support high-quality industry development [6]. - Continuous training programs have been conducted, with over 10,000 participants, to enhance the professional skills of regulatory personnel [6]. - Competitions and events have been organized to showcase the capabilities of the drug inspection industry in Sichuan [6]. Group 4: Comprehensive Safety Control - A systematic approach has been adopted to ensure safety throughout the entire drug lifecycle, from research and development to usage [7]. - The administration has conducted over 60,000 inspections in the past five years, achieving a compliance rate of 99.6% for drugs and 98.2% for medical devices [8]. - Collaborative efforts with Chongqing have been initiated to create an integrated drug regulatory model, enhancing regional cooperation [8]. Group 5: Industry Support and Innovation - The Sichuan Provincial Drug Administration is addressing barriers to innovation in the pharmaceutical industry by launching a user community platform for medical devices [9]. - A proactive service model has been implemented to support enterprises, reducing the average review time for innovative products by 86% [10]. - The administration has streamlined approval processes, significantly improving efficiency in drug and medical device registrations [11].

Group 1 - The forum "2025 New Consumption Summit for a Better Life" focused on high-quality and upgraded consumption in China's market, emphasizing the need for a healthier and more sustainable future [1] - Infinitus (China) Co., Ltd. was awarded the "Health Life Guardian" award for its systematic innovation in the health consumption sector [1] Group 2 - Infinitus has developed a quality control system that breaks the traditional health food industry's focus on end products rather than sourcing, implementing a "Seven Unification" planting management system across over 20 production areas [2] - The company uses DNA identification technology to ensure the purity of its mushroom strains, avoids chemical fertilizers and pesticides, and employs innovative techniques to enhance the stability and quality of its products [2] - Infinitus has established a dual inspection system in collaboration with institutions like Cambridge University and Zhejiang University, covering 38 testing indicators, and utilizes IoT technology for real-time data collection on its products [2] Group 3 - Infinitus creatively integrates traditional Chinese herbal wisdom with digital technology to meet the evolving consumer demand for holistic health, proposing health concepts that can be quantified through smart hardware and algorithms [3] - The company has transformed digital health services into a core value creation vehicle, allowing users to engage in health assessments and receive personalized recommendations, which in turn drives product iteration and service optimization [3] - Infinitus's systematic innovations not only enhance its market reputation and consumer trust but also exemplify the responsibility of Chinese enterprises in promoting high-quality development [3]